Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. (Q45126890)
Jump to navigation
Jump to search
scientific article published on 26 October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. |
scientific article published on 26 October 2004 |
Statements
Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis (English)
Antonio Tursi
Giovanni Brandimarte
Gian Marco Giorgetti
Giacomo Forti
Maria Ester Modeo